We have a deep understanding of and experience translating immuno-targeting technology into novel products as evidenced by our first approved product Lymphoseek®.  

We are exploring both immuno-diagnostic and immuno-therapeutic opportunities using the Manocept™ platform, the backbone underlying Lymphoseek.  Innovative immunodiagnostics and immunotherapeutics can and will make a difference for individuals – and families, physicians and care givers – touched by devastating conditions like cancer and other serious conditions.

Our Current pipeline includes:


Lymphoseek Life Cycle Management 

Immunodiagnostic Label Expansion  

Immunotherapeutics – Macrophage Therapeutics  


Market Development

Pipeline ImagePipeline Image